BeOne Medicines Ltd. — Director's Dealing 2019

Jun 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2019-06-17

Reporting Person: Yi Qingqing (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-17	Ordinary Shares	J	9282	—	Disposed	0	Direct

Footnotes

F1: Represents a transfer of shares by Qingqing Yi ("Mr. Yi") to certain funds managed by his employer and for whose benefit he was holding the shares. Mr. Yi expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.

F2: The 9,290 restricted share units ("RSUs") previously reported by Mr. Yi on June 8, 2018 were revised to 9,282 RSUs to be divisible by 13, as each of the Issuer's American Depositary Shares represents 13 Ordinary Shares. The Share Options previously reported by Mr. Yi on the same date were revised to 17,433 Share Options for the same reason.